Spots Global Cancer Trial Database for Efficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Efficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast Cancer

Official Title: Efficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast Cancer: Correlation Between MRI and Histology. Single-Center, Single-Arm, Non-Randomized Trial

Study ID: NCT03560102

Conditions

Breast Cancer, Invasive Ductal

Interventions

Philips Sonalleve® MR-HIFU Breast Therapy System

Study Description

Brief Summary: The purpose of the study is to evaluate the efficacy of a dedicated Magnetic Resonance guided High Intensity Focused Ultrasound (MR-HIFU) unit in ablating breast cancer by comparing MR imaging and pathologic specimen after resection. Single-center, single-arm, non-randomized trial

Detailed Description: The dedicated MR-HIFU unit has been shown to be safe and feasible to ablate breast tissue. The planned study should address the possibility to completely ablate breast cancer with the dedicated breast MR-HIFU unit. The result of the MR-HIFU therapy should be monitored by imaging (contrast enhanced MRI) as well as with histopathological correlation after surgery. The patient population would consist of female patients with proven breast cancer scheduled for surgical lumpectomy or mastectomy. The idea is to evaluate a minimal invasive method to treat breast cancer as a potential alternative to surgical resection in the future